Skip to main content
Clinical Trials/ACTRN12616001624471
ACTRN12616001624471
Active, not recruiting
未知

Knee-Fix study : A prospective, randomised, controlled trial of cemented vs uncemented total knee replacement. A study comparing Stryker Triathlon TKR

orth Shore Hospital Waitemata DHB0 sites316 target enrollmentNovember 24, 2016

Overview

Phase
未知
Intervention
Not specified
Conditions
knee osteoarthritis
Sponsor
orth Shore Hospital Waitemata DHB
Enrollment
316
Status
Active, not recruiting
Last Updated
3 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
November 24, 2016
End Date
TBD
Last Updated
3 years ago
Study Type
Interventional
Sex
All

Investigators

Sponsor
orth Shore Hospital Waitemata DHB

Eligibility Criteria

Inclusion Criteria

  • \*The patient is a male or non\-pregnant female between the ages of 40\-75 years.
  • \*Patient is deemed appropriate for a cruciate retaining knee replacement.
  • \*The patient has a primary diagnosis of osteoarthritis (OA).
  • \*The patient has intact collateral ligaments.
  • \*The patient has signed the study specific, ethics\-approved, Informed Consent document.
  • \*The patient is willing and able to comply with the specified pre\-operative and post\-operative clinical and radiographic evaluations.

Exclusion Criteria

  • \* The patient has a history of total, unicompartmental reconstruction or fusion of the affected joint.
  • \* Patient has had a previous osteotomy around the knee.
  • \* The patient is morbidly obese (BMI greater than 41\).
  • \* The patient has a deformity which will require the use of stems, wedges or augments in conjunction with the Triathlon Total Knee System.
  • \* The patient has a varus/valgus malalignment greater than 20 degrees (relative to mechanical axis).
  • \* The patient has a fixed flexion deformity greater than 20 degrees.
  • \* The patient has a neuromuscular or neurosensory deficiency, which would limit the ability to assess the performance of the device.
  • \* The patient has a systemic or metabolic disorder leading to progressive bone deterioration or poor bone quality.
  • \* The patient is immunologically suppressed or receiving steroids in excess of normal physiological requirements.
  • \* Patient has a cognitive impairment, an intellectual disability or a mental illness.

Outcomes

Primary Outcomes

Not specified

Similar Trials